Results 141 to 150 of about 2,048,259 (212)
Marte Karen Lindstad, Brattås +1 more
openaire +1 more source
Luspatercept (Luspa) is a first-in-class erythroid maturation agent approved for transfusion dependent anemia refractory or ineligible to ESAs in patients with low risk MDS-RS.
S. Leone +20 more
doaj
An Autopsy Case of Severe COVID-19 Pneumonia Complicated by Intrapulmonary Thrombosis in Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis. [PDF]
Harada Y +9 more
europepmc +1 more source
Evolution of myelodisplasic syndrome with ring sideroblasts (MDS-RS) to systemic mastocytosis and aleukemic mast cell leukemia. [PDF]
Costa LD +8 more
europepmc +1 more source
Congenital Dyserythropoetic Anemia with Sideroblasts and Ringed Forms
Khaled Kamaleddin, Mohamed +1 more
openaire +2 more sources
[Luspatercept combined with roxadustat in the treatment of refractory myelodysplastic neoplasms with ring sideroblasts: a prospective, randomized, single-center study]. [PDF]
Lu XY +5 more
europepmc +1 more source

